Concourse Financial Group Securities, Inc. Marker Therapeutics, Inc. Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding MRKR
# of Institutions
5Shares Held
475KCall Options Held
0Put Options Held
0About Marker Therapeutics, Inc.
- Ticker MRKR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,599,200
- Market Cap $255M
- Description
- Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...